DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 155.93 USD -0.86%
Market Cap: 13.1B USD
Have any thoughts about
DaVita Inc?
Write Note

DaVita Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DaVita Inc
Cost of Revenue Peer Comparison

Comparables:
CHE
DGX
CVS
CI
LH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
DaVita Inc
NYSE:DVA
Cost of Revenue
-$8.5B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Chemed Corp
NYSE:CHE
Cost of Revenue
-$1.5B
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.4B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$316.5B
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$206.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$9.2B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
-9%

See Also

What is DaVita Inc's Cost of Revenue?
Cost of Revenue
-8.5B USD

Based on the financial report for Sep 30, 2024, DaVita Inc's Cost of Revenue amounts to -8.5B USD.

What is DaVita Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
0%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for DaVita Inc have been -2% over the past three years , -1% over the past five years .

Back to Top